The drug lenvatinib can significantly improve overall survival rates in a group of thyroid cancer patients whose disease is resistant to
standard radioiodine treatment, according to new research from the Perelman School of Medicine at the University of Pennsylvania.
Lucy, J, Peterson ME, Randolph J, Scrivani P, Thompson M, Davignon D, Scarlett J. Efficacy of low - dose (2 millicurie) versus
standard - dose (4 millicurie)
radioiodine (131I) treatment for cats with mild - to - moderate hyperthyroidism.